{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:18:26Z","timestamp":1766150306303,"version":"3.48.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-07406-1","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:35Z","timestamp":1766150075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["IL-21 attenuates liver inflammation by enhancing myeloid-derived suppressor cells immunosuppressive function in chronic HBV infection"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiaoyi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zihan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meihan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyu","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhipeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihong","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiying","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Libo","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GuiRong","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6303-7642","authenticated-orcid":false,"given":"Yongyin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"7406_CR1","unstructured":"Fact sheet: hepatitis B Available from: https:\/\/www.who.int\/en\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"issue":"9663","key":"7406_CR2","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"LY Cc","year":"2009","unstructured":"Cc LY. Hepatitis B virus infection. Lancet. 2009;373(9663):582\u201392.","journal-title":"Lancet"},{"issue":"1","key":"7406_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","volume":"77","author":"R Thimme","year":"2003","unstructured":"Thimme R, Wieland S, Steiger C, et al. CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 2003;77(1):68\u201376.","journal-title":"J Virol"},{"issue":"2","key":"7406_CR4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1055\/s-2007-979468","volume":"27","author":"B Rehermann","year":"2007","unstructured":"Rehermann B. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses. Semin Liver Dis. 2007;27(2):152\u201360.","journal-title":"Semin Liver Dis"},{"issue":"3","key":"7406_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri3623","volume":"14","author":"A Pellicoro","year":"2014","unstructured":"Pellicoro A, Ramachandran P, Iredale JP, et al. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14(3):181\u201394.","journal-title":"Nat Rev Immunol"},{"key":"7406_CR6","doi-asserted-by":"crossref","unstructured":"Cho HJ, Cheong JY. Role of immune cells in patients with hepatitis B virus-related hepatocellular carcinoma. Int J Mol Sci. 2021;22(15).","DOI":"10.3390\/ijms22158011"},{"key":"7406_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3389\/fimmu.2020.00849","volume":"11","author":"P Fisicaro","year":"2020","unstructured":"Fisicaro P, Barili V, Rossi M, et al. Pathogenetic mechanisms of T cell dysfunction in chronic HBV infection and related therapeutic approaches. Front Immunol. 2020;11:849.","journal-title":"Front Immunol"},{"issue":"2","key":"7406_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41590-017-0022-x","volume":"19","author":"F Veglia","year":"2018","unstructured":"Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nat Immunol. 2018;19(2):108\u201319.","journal-title":"Nat Immunol"},{"issue":"1","key":"7406_CR9","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/2326-6066.CIR-16-0297","volume":"5","author":"DI Gabrilovich","year":"2017","unstructured":"Gabrilovich DI. Myeloid-derived suppressor cells. Cancer Immunol Res. 2017;5(1):3\u20138.","journal-title":"Cancer Immunol Res"},{"issue":"9","key":"7406_CR10","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.4049\/jimmunol.1402004","volume":"194","author":"J Wang","year":"2015","unstructured":"Wang J, Shirota Y, Bayik D, et al. Effect of tlr agonists on the differentiation and function of human monocytic myeloid-derived suppressor cells. The J Immunol. 2015;194(9):4215\u201321.","journal-title":"The J Immunol"},{"issue":"1","key":"7406_CR11","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3390\/cancers6010472","volume":"6","author":"N Espagnolle","year":"2014","unstructured":"Espagnolle N, Barron P, Mandron M, et al. Specific inhibition of the VEGFR-3 tyrosine kinase by SAR131675 reduces peripheral and tumor associated immunosuppressive myeloid cells. Cancers (basel). 2014;6(1):472\u201390.","journal-title":"Cancers (basel)"},{"key":"7406_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.canlet.2019.10.020","volume":"469","author":"Z Liu","year":"2020","unstructured":"Liu Z, Xie Y, Xiong Y, et al. Tlr 7\/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages. Cancer Lett. 2020;469:173\u201385.","journal-title":"Cancer Lett"},{"issue":"5","key":"7406_CR13","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.7150\/thno.65916","volume":"12","author":"G Liu","year":"2022","unstructured":"Liu G, Wang Q, Deng L, et al. Hepatic RACK1 deficiency protects against fulminant hepatitis through myeloid-derived suppressor cells. Theranostics. 2022;12(5):2248\u201365.","journal-title":"Theranostics"},{"issue":"4","key":"7406_CR14","doi-asserted-by":"publisher","first-page":"e1007690","DOI":"10.1371\/journal.ppat.1007690","volume":"15","author":"F Yang","year":"2019","unstructured":"Yang F, Yu X, Zhou C, et al. Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog. 2019;15(4):e1007690.","journal-title":"PLoS Pathog"},{"issue":"6","key":"7406_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nm.3856","volume":"21","author":"LJ Pallett","year":"2015","unstructured":"Pallett LJ, Gill US, Quaglia A, et al. Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells. Nat Med. 2015;21(6):591\u2013600.","journal-title":"Nat Med"},{"key":"7406_CR16","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3389\/fimmu.2020.00783","volume":"11","author":"A Hou","year":"2020","unstructured":"Hou A, Hou K, Huang Q, et al. Targeting myeloid-derived suppressor cell, a promising strategy to overcome resistance to immune checkpoint inhibitors. Front Immunol. 2020;11:783.","journal-title":"Front Immunol"},{"issue":"5","key":"7406_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/infdis\/jiy576","volume":"219","author":"L Tang","year":"2019","unstructured":"Tang L, Chen C, Gao X, et al. Interleukin 21 reinvigorates the antiviral activity of hepatitis B virus (HBV)-specific CD8+ T cells in chronic HBV infection. J Infect Dis. 2019;219(5):750\u201359.","journal-title":"The J Infect Dis"},{"issue":"4","key":"7406_CR18","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/hep.26489","volume":"58","author":"Y Li","year":"2013","unstructured":"Li Y, Ma S, Tang L, et al. Circulating chemokine (C-X-C motif) receptor 5(+) CD4(+) T cells benefit hepatitis B e antigen seroconversion through IL-21 in patients with chronic hepatitis B virus infection. Hepatology. 2013;58(4):1277\u201386.","journal-title":"Hepatology"},{"issue":"7","key":"7406_CR19","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2893.2011.01475.x","volume":"18","author":"X Hu","year":"2011","unstructured":"Hu X, Ma S, Huang X, et al. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hepat. 2011;18(7):458\u201367.","journal-title":"J Viral Hepat"},{"issue":"1","key":"7406_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/hep.23273","volume":"51","author":"JY Zhang","year":"2010","unstructured":"Zhang JY, Zhang Z, Lin F, et al. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 2010;51(1):81\u201391.","journal-title":"Hepatology"},{"issue":"3","key":"7406_CR21","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50(3):661\u201362.","journal-title":"Hepatology"},{"issue":"47","key":"7406_CR22","doi-asserted-by":"publisher","first-page":"17862","DOI":"10.1073\/pnas.0608578103","volume":"103","author":"LR Huang","year":"2006","unstructured":"Huang LR, Wu HL, Chen PJ, et al. An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A. 2006;103(47):17862\u201367.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7406_CR23","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.jhep.2019.09.031","volume":"72","author":"Y Li","year":"2020","unstructured":"Li Y, Tang L, Guo L, et al. CXCL13-mediated recruitment of intrahepatic CXCR5(+)CD8(+) T cells favors viral control in chronic HBV infection. J Hepatol. 2020;72(3):420\u201330.","journal-title":"J Hepatol"},{"issue":"10","key":"7406_CR24","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.4049\/jimmunol.1501362","volume":"195","author":"Z Fang","year":"2015","unstructured":"Fang Z, Li J, Yu X, et al. Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK\/IL-6\/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection. J Immunol. 2015;195(10):4873\u201383.","journal-title":"The J Immunol"},{"key":"7406_CR25","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","volume":"7","author":"V Bronte","year":"2016","unstructured":"Bronte V, Brandau S, Chen SH, et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun. 2016;7:12150.","journal-title":"Nat Commun"},{"key":"7406_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev.immunol.26.021607.090316","volume":"26","author":"R Spolski","year":"2008","unstructured":"Spolski R, Leonard WJ. Interleukin-21: basic biology and implications for cancer and autoimmunity. Annu Rev Immunol. 2008;26:57\u201379.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"7406_CR27","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","volume":"32","author":"T Condamine","year":"2011","unstructured":"Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends Immunol. 2011;32(1):19\u201325.","journal-title":"Trends Immunol"},{"issue":"9663","key":"7406_CR28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","volume":"373","author":"Y-F Liaw","year":"2009","unstructured":"Liaw Y-F, Chu C-M. Hepatitis B virus infection. Lancet. 2009;373(9663):582\u201392.","journal-title":"Lancet"},{"issue":"4","key":"7406_CR29","doi-asserted-by":"publisher","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","volume":"5","author":"JT Pesce","year":"2009","unstructured":"Pesce JT, Ramalingam TR, Mentink-Kane MM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5(4):e1000371.","journal-title":"PLoS Pathog"},{"issue":"3","key":"7406_CR30","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.32331","volume":"76","author":"S Pal","year":"2022","unstructured":"Pal S, Dey D, Chakraborty BC, et al. Diverse facets of MDSC in different phases of chronic HBV infection: impact on HBV-specific T-cell response and homing. Hepatology. 2022;76(3):759\u201374.","journal-title":"Hepatology"},{"key":"7406_CR31","doi-asserted-by":"crossref","unstructured":"Asao H. Interleukin-21 in viral infections. Int J Mol Sci. 2021;22(17).","DOI":"10.3390\/ijms22179521"},{"issue":"3","key":"7406_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/cmi.2014.109","volume":"12","author":"Y Li","year":"2015","unstructured":"Li Y, Tang L, Hou J. Role of interleukin-21 in HBV infection: friend or foe? Cell Mol Immunol. 2015;12(3):303\u201308.","journal-title":"Cell Mol Immunol"},{"issue":"9","key":"7406_CR33","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1111\/jvh.12242","volume":"21","author":"Q Pan","year":"2014","unstructured":"Pan Q, Yu Y, Tang Z, et al. Increased levels of IL-21 responses are associated with the severity of liver injury in patients with chronic active hepatitis B. J Viral Hepat. 2014;21(9):e78\u201388.","journal-title":"J Viral Hepat"},{"key":"7406_CR34","doi-asserted-by":"publisher","first-page":"31881","DOI":"10.1038\/srep31881","volume":"6","author":"Y Wang","year":"2016","unstructured":"Wang Y, Jiang X, Zhu J, et al. IL-21\/IL-21R signaling suppresses intestinal inflammation induced by DSS through regulation of Th responses in lamina propria in mice. Sci Rep. 2016;6:31881.","journal-title":"Sci Rep"},{"issue":"11","key":"7406_CR35","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.4049\/jimmunol.1400849","volume":"193","author":"A Huang","year":"2014","unstructured":"Huang A, Zhang B, Yan W, et al. Myeloid-derived suppressor cells regulate immune response in patients with chronic hepatitis B virus infection through PD-1-induced IL-10. The J Immunol. 2014;193(11):5461\u201369.","journal-title":"The J Immunol"},{"issue":"3","key":"7406_CR36","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1136\/gut.2008.163527","volume":"58","author":"EK Geissler","year":"2009","unstructured":"Geissler EK, Schlitt HJ. Immunosuppression for liver transplantation. Gut. 2009;58(3):452\u201363.","journal-title":"Gut"},{"issue":"6","key":"7406_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1189\/jlb.4RI0515-204R","volume":"98","author":"T Condamine","year":"2015","unstructured":"Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells. J Leukoc Biol. 2015;98(6):913\u201322.","journal-title":"J Leukoc Biol"},{"key":"7406_CR38","doi-asserted-by":"publisher","first-page":"619253","DOI":"10.3389\/fimmu.2020.619253","volume":"11","author":"N Fultang","year":"2020","unstructured":"Fultang N, Li X, Li T, et al. Myeloid-derived suppressor cell differentiation in cancer: transcriptional regulators and Enhanceosome-mediated mechanisms. Front Immunol. 2020;11:619253.","journal-title":"Front Immunol"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07406-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-07406-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-07406-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T13:14:36Z","timestamp":1766150076000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-025-07406-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7406"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-07406-1","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All individuals provided written informed consent, and the Ethical Committee of Nanfang Hospital approved the studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have viewed and agreed to publish this paper.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1410"}}